Field-collected ticks were used to infect goats with either Ap-ha, a strain associated with human disease, or a variant strain, Ap-Variant 1, of Anaplasma phagocytophilum. Goats were shown to be competent as a reservoir for Ap-Variant 1, and challenge and immunosuppression studies were used to further examine infection in the goat model.
Ap-Variant 1 represents a distinct strain of Anaplasma phagocytophilum that has not been associated with human disease. White-tailed deer (Odocoileus virginianus) appear to serve as a natural reservoir for Ap-Variant 1, and to date they are the only vertebrate species known to harbor this strain (1, 6, 7) . However, deer are difficult to use in a laboratory setting and require specialized large animal facilities. Therefore, the potential for the domestic goat to serve as a smaller ruminant animal model was examined. The competency of goats as a natural reservoir for Ap-Variant 1 was also evaluated by tickfeeding and transmission studies.
Questing adult and nymphal ticks were collected by flagging from South Kingstown, Rhode Island, and allowed to feed on three pathogen-free goats. Two of the goats (A and B) became infected with A. phagocytophilum strains whose 16S rRNA sequences matched that of the human pathogenic strain Ap-ha. The third goat (goat C) became infected with the Ap-Variant 1 strain, as demonstrated by PCR amplification from blood and DNA sequencing, as previously described (8) . EDTA-treated blood (3.5 ml) collected from goat C at 3 weeks postinfection was used to infect goat D with Ap-Variant 1. This showed that the DNA detected by PCR in the blood of goat C represented viable organisms. Larval and nymphal ticks were allowed to feed on goat C, allowed to molt, and fed on goat E, which became infected with Ap-Variant 1, thereby demonstrating the reservoir competency of goats.
Blood smears were prepared from goat D on day 14 postinjection, stained for visualization of cellular morphology, and fluorescein labeled using anti-A. phagocytophilum antibodies (Fig. 1) . The fluorescein-labeled image (Fig. 1B) demonstrates that Ap-Variant 1 was detected only in segmented neutrophils. Blood samples from goats C, D, and E were collected sequentially and assessed for infection and serological titers. End-point titers in the sera were determined by an immunofluorescence assay using a fluorescein isothiocyanate-labeled rabbit anti-goat conjugate (Rockland Immunochemicals, Gilbertsville, PA). Table 1 summarizes the source of infection and PCR, DNA sequencing, and immunofluorescence assay results for each of the five goats. Only goat A showed signs of clinical illness, including fever, lethargy, lameness, loss of appetite, and nasal discharge. Goat E was further tested every 2 to 3 days for 3 months by use of complete blood counts with differential and serum chemistry profiles. Goat E had a slightly elevated temperature (103.5°F) on day 7 postinfestation only and showed mild and transient neutropenia and lymphopenia on days 10 and 7 postinfestation, respectively. Otherwise, goat E showed normal serum profiles and blood cell counts during the infection and through 3 months postinfestation.
Although each of the three goats infected with Ap-Variant 1 were PCR positive for various lengths of time, the infections appeared to be cleared because each goat was PCR negative past day 24. To assess the clearance of Ap-Variant 1 in goats, goat D was treated on day 110 postinfection and for five consecutive days with an intramuscular dose (4 mg/kg body weight) of dexamethasone as a strong immunosuppression regimen (3, 4) . Goat D remained PCR negative through day 32 posttreatment, and the serum titer remained stable, at Յ128. These results suggest that goat D had cleared the Ap-Variant 1 infection.
Goat C was treated with a regimen of the antibiotic oxytetracycline (10) at 3 months postinfection and, 25 days after treatment, infested with 50 nymphal ticks that were infected with Ap-ha. This goat became PCR positive on day 11 and remained positive through day 25, and the infectious agent was confirmed to be Ap-ha by DNA sequencing. Whereas the titer of goat C was 1/32 prior to the challenge, by day 21 postinfestation the titer had risen to 1/Ͼ2,048. These results demonstrate that the immune response induced by infection with Ap-Variant 1 did not provide protection from a subsequent infection with Ap-ha. This is in agreement with prior studies where sheep and mice were not protected when challenged with heterologous strains of A. phagocytophilum (5, 11) .
Our ability to characterize the biological and molecular features of Ap-Variant 1 has been limited by several factors, primarily the lack of a tissue culture isolate of the agent and the lack of an animal model for laboratory studies. The current study addresses the latter of these needs and demonstrates that the domestic goat can be infected by the Ap-Variant 1 strain and is competent as a reservoir for maintenance of the agent in a natural vertebrate host-tick vector cycle. Blood from infected goats also provides an excellent resource for ongoing attempts to make a tissue culture isolate of the variant strain. The availability of sera from Ap-Variant 1-infected goats also provides a useful reagent that can be applied to characterizing the Ap-Variant 1 strain by use of Western blots, immunoprecipitation, or other methods for examining the antigenic composition of the agent.
Ap-Variant 1 has now been shown to infect goats and white-tailed deer but is not infectious in mice, hamsters, and gerbils (7; data not shown). These data suggest that ApVariant 1 is restricted to ruminant species and represents a lineage distinct from Ap-ha, which infects humans and numerous other mammals. A similar distinction between ruminant and nonruminant lineages in Europe has been suggested (9) . However, the pathogenic potentials of ruminant strains from Europe and North America appear to differ dramatically. Tick-borne fever in Europe is a well-documented disease of sheep, cattle, and goats characterized by an acute febrile illness, with mortality rates as high as 30% in lamb herds (2, (12) (13) (14) . In contrast, our experimental Ap-Variant 1 infections of goats caused few apparent clinical symptoms. This suggests that the North American ApVariant 1 strain has evolved into a less pathogenic form than the European ruminant strains. While Ap-Variant 1 has low pathogenic potential based on our experimental infections, it may be that the agent causes morbidity and mortality in a domestic or wildlife species that has not yet been examined. Continued studies are needed to examine the host range of Ap-Variant 1 to determine if ruminants other than whitetailed deer and goats are susceptible to infection and whether restriction of the variant to ruminant species is absolute.
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